DE69913351D1 - Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen - Google Patents

Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen

Info

Publication number
DE69913351D1
DE69913351D1 DE69913351T DE69913351T DE69913351D1 DE 69913351 D1 DE69913351 D1 DE 69913351D1 DE 69913351 T DE69913351 T DE 69913351T DE 69913351 T DE69913351 T DE 69913351T DE 69913351 D1 DE69913351 D1 DE 69913351D1
Authority
DE
Germany
Prior art keywords
shielding
metal complexes
chlorine derivatives
ray rays
ray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69913351T
Other languages
English (en)
Other versions
DE69913351T2 (de
Inventor
Katsuo Aizawa
Shinjiro Sumi
Hirotada Takahashi
Noriaki Aman
Yoshihiko Terayama
Shuichi Gomi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Seika Kaisha Ltd
Original Assignee
Meiji Seika Kaisha Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha Ltd filed Critical Meiji Seika Kaisha Ltd
Publication of DE69913351D1 publication Critical patent/DE69913351D1/de
Application granted granted Critical
Publication of DE69913351T2 publication Critical patent/DE69913351T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0085Mossbauer effect therapy based on mossbauer effect of a material, i.e. re-emission of gamma rays after absorption of gamma rays by the material; selective radiation therapy, i.e. involving re-emission of ionizing radiation upon exposure to a first ionizing radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/545Heterocyclic compounds
    • A61K47/546Porphyrines; Porphyrine with an expanded ring system, e.g. texaphyrine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
DE69913351T 1998-07-10 1999-07-12 Metallkomplexe von Chlorinderivaten zum Abschirmen von Röntgenstrahlen Expired - Lifetime DE69913351T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP19571798 1998-07-10
JP19571798 1998-07-10
PCT/JP1999/003752 WO2000002882A1 (fr) 1998-07-10 1999-07-12 Nouveaux complexes metalliques intercepteurs de rayons x a base de derives de chlore

Publications (2)

Publication Number Publication Date
DE69913351D1 true DE69913351D1 (de) 2004-01-15
DE69913351T2 DE69913351T2 (de) 2004-09-16

Family

ID=16345803

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69913351T Expired - Lifetime DE69913351T2 (de) 1998-07-10 1999-07-12 Metallkomplexe von Chlorinderivaten zum Abschirmen von Röntgenstrahlen

Country Status (9)

Country Link
US (1) US6413495B1 (de)
EP (1) EP1097935B1 (de)
JP (1) JP3692298B2 (de)
AT (1) ATE255583T1 (de)
AU (1) AU748625B2 (de)
CA (1) CA2336582C (de)
DE (1) DE69913351T2 (de)
ES (1) ES2212577T3 (de)
WO (1) WO2000002882A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE386514T1 (de) * 1999-04-02 2008-03-15 Meiji Seika Kaisha Inhibition der vaskulären restenose nach einer angioplastie
EP1363548B1 (de) 2000-11-24 2015-08-12 Koninklijke Philips N.V. Vorrichtung zur diagnostizierung, bilderzeugung und medizinischen intervention
EP1351619A4 (de) 2001-01-16 2011-01-05 Microdexterity Systems Inc Chirurgischer manipulator
IL147898A (en) * 2002-01-30 2007-05-15 Yuval Golan A method of treating cancer based on the Ugar effect
US10376711B2 (en) * 2003-03-14 2019-08-13 Light Sciences Oncology Inc. Light generating guide wire for intravascular use
CN2885311Y (zh) 2006-01-18 2007-04-04 郑成福 经尿道光动力疗法前列腺治疗仪
JP4960602B2 (ja) * 2005-04-15 2012-06-27 三鷹光器株式会社 蛍光観察時の明視野光源及びそれを搭載した手術顕微鏡
AU2009347929A1 (en) * 2009-06-12 2012-01-19 Amrita Vishwa Vidyapeetham University Targeted nano-photomedicines for photodynamic therapy of cancer
RU2455039C1 (ru) * 2011-03-14 2012-07-10 Виктор Александрович Борисов Способ фотодинамической терапии злокачественных новообразований
CA2907356C (en) 2013-03-15 2022-07-12 Sherri Ann MCFARLAND Metal-based coordination complexes as photodynamic compounds and their use
US10149493B2 (en) 2015-04-29 2018-12-11 Corn Products Development, Inc. Flours that improve the crispness of battered potatoes
AU2016326737B2 (en) 2015-09-24 2023-01-12 Abvitro Llc Affinity-oligonucleotide conjugates and uses thereof
PL236093B1 (pl) 2017-07-04 2020-11-30 Dominika Szczepaniak Rozpuszczalne w wodzie kompleksy złota (III), sposób wytwarzania rozpuszczalnych w wodzie kompleksów złota (III) i ich zastosowanie
PL244960B1 (pl) 2021-02-15 2024-04-08 Dominika Szczepaniak Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693885A (en) * 1984-07-18 1987-09-15 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
US4675338A (en) * 1984-07-18 1987-06-23 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
GB8426102D0 (en) * 1984-10-16 1984-11-21 Ici Plc Thermal transfer printing
US4921973A (en) * 1984-12-10 1990-05-01 Johnson Matthey Inc. Platinum complexes and the like
US4815447A (en) * 1985-03-19 1989-03-28 Mills Randell L Mossbauer cancer therapy
US4656186A (en) * 1985-04-30 1987-04-07 Nippon Petrochemicals Co., Ltd. Tetrapyrrole therapeutic agents
DE3827940A1 (de) * 1988-08-13 1990-03-01 Schering Ag 13,17-propionsaeure- und propionsaeurederivat- substituierte porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JP3253663B2 (ja) * 1992-01-20 2002-02-04 タマ生化学株式会社 放射線増感剤

Also Published As

Publication number Publication date
JP3692298B2 (ja) 2005-09-07
EP1097935A1 (de) 2001-05-09
CA2336582C (en) 2006-06-06
EP1097935A4 (de) 2002-01-30
US6413495B1 (en) 2002-07-02
CA2336582A1 (en) 2000-01-20
ES2212577T3 (es) 2004-07-16
ATE255583T1 (de) 2003-12-15
AU748625B2 (en) 2002-06-06
AU4651099A (en) 2000-02-01
WO2000002882A1 (fr) 2000-01-20
EP1097935B1 (de) 2003-12-03
DE69913351T2 (de) 2004-09-16

Similar Documents

Publication Publication Date Title
DE69913351D1 (de) Metallkomplexe von chlorinderivaten zum abschirmen von röntgenstrahlen
NO20006155D0 (no) Texaphyrinkonjugater og anvendelse derav
RU92016479A (ru) Применение 5,10,15,20-тетракис (4-карбоксифенил) порфина для обнаружения и лечения рака легких
NO20040239L (no) Konjugater av makrosykliske metallkomplekser med biomolekyler og anvendelse derav til fremstilling av midler for anvendelse i NMR- og røntgendiagnose, samt ved strålebehandling
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
RU93051543A (ru) Производные акридина, способ получения, фармацевтическая композиция и способ лечения злокачественных опухолей
TR200003879T2 (tr) İn vivo ışın tedavisine duyarlılaştırıcı özelliklere sahip farnesil protein transferaz inhibitörleri@
MY121548A (en) Compounds and methods for the treatment of cancer
AU6198086A (en) Agents for use in tumour diagnosis, imaging, localization or treatment
NO994932L (no) Blandinger og fremgangsmåter for behandling og diagnose av brystkreft
ATE262515T1 (de) Discodermolide verbindungen und deren pharmazeutische zusammensetzungen zur krebstherapie
ATE306281T1 (de) Antivirales mittel in kombination mit strahlentherapie zur verwendung in der behandlung von krebs
GB2393123A (en) Novel metalloporphyrins and their uses as radiosensitizers for radiation therapy
IL97055A0 (en) Pharmaceutical compositions for sensitizing tumor cells comprising quinazolinedione derivatives
DE68926913D1 (de) Chelatbildende Verbindungen, die eine ortho-bindende Gruppe besitzen und ihre Komplexe
MX9200413A (es) Composicion farmaceutica para el tratamiento y/o diagnostico de tumores de tejido blando.
DK0730871T3 (da) Radioaktivt kompleks og anvendelsen heraf til strålebehandling
NO995109L (no) Formuleringer inneholdende 1,2,4-benzotriazinoksyder
TR200102576T2 (tr) Kanser tedavisinde radyoaktif sisplatin
SE8505315D0 (sv) Anordning for stralfeltsavskermning vid radioterapi
DK1154798T3 (da) Molekyler til behandling og diagnose af tumorer
Oren et al. Exposure to ultraviolet B radiation during phototherapy.
GR880100589A (en) Metalloporfyrines for the inversion of the toxic activity for the tumors treatment
ATE291620T1 (de) Mammakarzinom-assoziiertes gen
AU8436791A (en) Use of radioactive metal ion complexes with all-cis-1,3,5-triamino-2,4,6-cyclohexantriol and their derivates for x-ray diagnosis and in tumor therapy as well asfor producing x-ray diagnostic and tumor therapy agents

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1097935

Country of ref document: EP

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN, DE